| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.97B | 23.35B | 33.29B | 38.54B | 60.63B | 34.90B |
| Gross Profit | 5.54B | 5.47B | 9.65B | 10.31B | 16.80B | 11.12B |
| EBITDA | 5.36B | 5.13B | 7.73B | 7.64B | 13.66B | 7.72B |
| Net Income | 2.42B | 1.03B | 1.45B | 1.55B | 3.71B | 2.19B |
Balance Sheet | ||||||
| Total Assets | 43.08B | 46.32B | 48.81B | 50.66B | 56.86B | 53.80B |
| Cash, Cash Equivalents and Short-Term Investments | 3.51B | 6.17B | 7.03B | 8.30B | 9.56B | 6.35B |
| Total Debt | 10.01B | 10.86B | 9.41B | 9.13B | 10.28B | 10.85B |
| Total Liabilities | 23.38B | 25.74B | 24.20B | 25.29B | 30.24B | 31.80B |
| Stockholders Equity | 15.95B | 14.34B | 17.87B | 18.24B | 19.15B | 15.51B |
Cash Flow | ||||||
| Free Cash Flow | 782.28M | 1.31B | 1.94B | 2.22B | 4.82B | 4.52B |
| Operating Cash Flow | 4.64B | 5.01B | 5.46B | 5.71B | 7.76B | 7.02B |
| Investing Cash Flow | -4.65B | -2.65B | -3.15B | -3.03B | -1.97B | -1.82B |
| Financing Cash Flow | -2.98B | -2.72B | -3.13B | -3.77B | -2.66B | -2.98B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $134.72B | 3.80 | 27.02% | 14.10% | -2.43% | 171.38% | |
66 Neutral | $101.63B | 12.11 | 3.44% | 7.43% | 3.95% | -38.27% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
65 Neutral | $82.30B | 16.84 | 5.25% | 5.41% | -3.06% | 9.20% | |
63 Neutral | $120.03B | 7.90 | 5.52% | 5.62% | 4.29% | ― | |
60 Neutral | $23.06B | 13.36 | 6.75% | 9.56% | -19.37% | 141.35% |